CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-03-30 | PASSERI DANIEL R CEO and Director | Option exercise · Non-qualified stock option | −11,269 | $3.13 | $35K | 98,100 |
| 2011-03-30 | TOBIN JAMES R Director | Option exercise | +12,500 | $3.13 | $39K | 58,738 |
| 2011-03-30 | TOBIN JAMES R Director | Sale | −11,987 | $3.27 | $39K | 46,751 |
| 2011-03-30 | TOBIN JAMES R Director | Option exercise · Non-qualified stock option | −12,500 | $3.13 | $39K | 0 |
| 2011-03-30 | MCNAB JAMES R Director | Sale | −25,000 | $3.28 | $82K | 1,147,188 |
| 2011-03-29 | MCNAB JAMES R Director | Sale | −25,000 | $3.28 | $82K | 1,172,188 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise | +95,000 | $1.07 | $102K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise | +60,000 | $1.43 | $86K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise | +90,000 | $1.39 | $125K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise | +90,000 | $1.67 | $150K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise | +62,500 | $1.50 | $94K | 1,197,188 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +95,000 | $1.07 | $102K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +60,000 | $1.43 | $86K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +90,000 | $1.39 | $125K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +90,000 | $1.67 | $150K | 0 |
| 2011-03-18 | MCNAB JAMES R Director | Option exercise · Non-qualified stock option (right to buy) | +62,500 | $1.50 | $94K | 0 |
| 2011-01-07 | DAVIE JOSEPH MD PHD Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-01-07 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +85,000 | 85,000 | ||
| 2011-01-07 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-01-07 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 |
Page 22 of 29 · 564 trades